SEC Filings for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 10.40   0.05 (+0.48%) Volume: 336.06k 4:00 PM EST Dec 3, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)1911/20/2020
DEFA14AAdditional proxy soliciting materials - definitive810/28/2020
8-KCurrent report pursuant to Section 13 or 15(d)710/28/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)6210/23/2020
DEFA14AAdditional proxy soliciting materials - definitive310/07/2020
DEF 14AOther definitive proxy statements6610/07/2020
8-KCurrent report pursuant to Section 13 or 15(d)708/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
4Statement of changes in beneficial ownership of securities108/14/2020
<<
First
<
Prev
123456789101112131415